{ "company_number": "07982661", "name": "I.b.pharm Consultancy Ltd", "url": "/company/07982661", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2012-03-08", "dissolved_on": null, "sic_codes": [ { "code": "68209", "description": "Other letting and operating of own or leased real estate", "section": "L", "section_name": "Real estate activities", "url": "/sic/68209" } ], "registered_address": { "id": 1512281, "url": "/address/1512281", "line1": "7 MIDDLETON LANE", "line2": "MIDDLETON ST GEORGE", "post_town": "DARLINGTON", "county": "COUNTY DURHAM", "country": "UNITED KINGDOM", "postcode": "DL2 1AA" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07982661", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-01-31", "last_made_up": "2025-04-30", "category": "MICRO ENTITY", "filings": [ { "url": "/company/07982661/accounts/2025-04-30", "pdf_url": "/company/07982661/accounts/2025-04-30.pdf", "made_up_date": "2025-04-30", "period_start": "2025-04-30", "period_end": "2025-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "122131.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "3541.00", "creditors_due_within_one_year": "127433.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-123892.00", "total_assets_less_current_liabilities": "-1761.00", "net_assets_liabilities": "-2361.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-2361.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2026.zip" }, { "url": "/company/07982661/accounts/2024-04-30", "pdf_url": "/company/07982661/accounts/2024-04-30.pdf", "made_up_date": "2024-04-30", "period_start": "2024-04-30", "period_end": "2024-04-30", "entity_name": "I.b.pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "122132.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "5843.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1547.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2024.zip" }, { "url": "/company/07982661/accounts/2023-04-30", "pdf_url": "/company/07982661/accounts/2023-04-30.pdf", "made_up_date": "2023-04-30", "period_start": "2023-04-30", "period_end": "2023-04-30", "entity_name": "I.b.pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "122133.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "6786.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-1861.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2024.zip" }, { "url": "/company/07982661/accounts/2022-04-30", "pdf_url": "/company/07982661/accounts/2022-04-30.pdf", "made_up_date": "2022-04-30", "period_start": "2022-04-30", "period_end": "2022-04-30", "entity_name": "I.b.pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "122135.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "29140.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-127481.00", "total_assets_less_current_liabilities": "-5346.00", "net_assets_liabilities": "-5346.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-5346.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/07982661/accounts/2021-04-30", "pdf_url": "/company/07982661/accounts/2021-04-30.pdf", "made_up_date": "2021-04-30", "period_start": "2021-04-30", "period_end": "2021-04-30", "entity_name": "I.b.pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "122138.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "26161.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-129672.00", "total_assets_less_current_liabilities": "-7534.00", "net_assets_liabilities": "-7534.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-7534.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2022.zip" }, { "url": "/company/07982661/accounts/2020-04-30", "pdf_url": "/company/07982661/accounts/2020-04-30.pdf", "made_up_date": "2020-04-30", "period_start": "2020-04-30", "period_end": "2020-04-30", "entity_name": "I.b.pharm Consultancy Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "122141.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "25932.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-131595.00", "total_assets_less_current_liabilities": "-9454.00", "net_assets_liabilities": "-9454.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-9454.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2021.zip" }, { "url": "/company/07982661/accounts/2019-04-30", "pdf_url": "/company/07982661/accounts/2019-04-30.pdf", "made_up_date": "2019-04-30", "period_start": "2019-04-30", "period_end": "2019-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "122146.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "24020.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-131154.00", "total_assets_less_current_liabilities": "-9008.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-9008.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/07982661/accounts/2018-04-30", "pdf_url": "/company/07982661/accounts/2018-04-30.pdf", "made_up_date": "2018-04-30", "period_start": "2018-04-30", "period_end": "2018-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "25.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "2869.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-9174.00", "total_assets_less_current_liabilities": "-9149.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-9149.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2019.zip" }, { "url": "/company/07982661/accounts/2017-04-30", "pdf_url": "/company/07982661/accounts/2017-04-30.pdf", "made_up_date": "2017-04-30", "period_start": "2017-04-30", "period_end": "2017-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "33.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "2855.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-10267.00", "total_assets_less_current_liabilities": "-10234.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "-10234.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2018.zip" }, { "url": "/company/07982661/accounts/2016-04-30", "pdf_url": "/company/07982661/accounts/2016-04-30.pdf", "made_up_date": "2016-04-30", "period_start": "2016-04-30", "period_end": "2016-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "44.00", "debtors": "1328.00", "cash_bank_in_hand": "3387.00", "current_assets": "4715.00", "creditors_due_within_one_year": "8167.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-3452.00", "total_assets_less_current_liabilities": "-3408.00", "net_assets_liabilities": "-3417.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-3517.00", "shareholder_funds": "-3417.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-August2016.zip" }, { "url": "/company/07982661/accounts/2015-04-30", "pdf_url": "/company/07982661/accounts/2015-04-30.pdf", "made_up_date": "2015-04-30", "period_start": "2015-04-30", "period_end": "2015-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "334.00", "debtors": null, "cash_bank_in_hand": "9788.00", "current_assets": "11588.00", "creditors_due_within_one_year": "6611.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4977.00", "total_assets_less_current_liabilities": "5311.00", "net_assets_liabilities": "5244.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "5144.00", "shareholder_funds": "5244.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2015.zip" }, { "url": "/company/07982661/accounts/2014-04-30", "pdf_url": "/company/07982661/accounts/2014-04-30.pdf", "made_up_date": "2014-04-30", "period_start": "2014-04-30", "period_end": "2014-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "627.00", "debtors": "1100.00", "cash_bank_in_hand": "6325.00", "current_assets": "8625.00", "creditors_due_within_one_year": "4955.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3670.00", "total_assets_less_current_liabilities": "4297.00", "net_assets_liabilities": "4172.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "4072.00", "shareholder_funds": "4172.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2014.zip" }, { "url": "/company/07982661/accounts/2013-04-30", "pdf_url": "/company/07982661/accounts/2013-04-30.pdf", "made_up_date": "2013-04-30", "period_start": "2013-04-30", "period_end": "2013-04-30", "entity_name": "I.B.Pharm Consultancy Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "924.00", "debtors": "1088.00", "cash_bank_in_hand": "5172.00", "current_assets": "6260.00", "creditors_due_within_one_year": "5261.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "999.00", "total_assets_less_current_liabilities": "1923.00", "net_assets_liabilities": "1738.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "1638.00", "shareholder_funds": "1738.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2013.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07982661/filing-history" }, "confirmation_statement": { "next_due": "2027-03-22", "last_made_up": "2026-03-08" }, "officers": [], "psc": [ { "name": "Mr Ian Bell", "kind": "individual-person-with-significant-control", "person_url": "/person/1954646", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-50-to-75-percent", "voting-rights-50-to-75-percent", "right-to-appoint-and-remove-directors" ], "notified_on": "2016-04-06", "ceased_on": "2018-12-19", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mrs Katherine Bell", "kind": "individual-person-with-significant-control", "person_url": "/person/2612923", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent", "voting-rights-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": "2018-12-19", "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-20T03:25:37.487954+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }